Mounjaro outsold Ozempic in 2025 with $23.0B in sales to Ozempic's $19.2B
Exploding Topics ranks the top GLP-1 sellers of 2025, with Lilly's Zepbound also pulling in $13.5B behind its two bigger rivals.
Recap by typeshit. Post by Exploding Topics on X.